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Background: As public health efforts seek to eradicate malaria, there has been an emphasis on eliminating
low-density parasite reservoirs in asymptomatic carriers. As such, diagnosing submicroscopic Plasmodium infections
using PCR-based techniques has become important not only in clinical trials of malaria vaccines and therapeutics,
but also in active malaria surveillance campaigns. However, PCR-based quantitative assays that rely on nucleic acid
extracted from dried blood spots (DBS) have demonstrated lower sensitivity than assays that use cryopreserved
whole blood as source material.
Methods: The density of Plasmodium falciparum asexual parasites was quantified using genomic DNA extracted
from dried blood spots (DBS) and the sensitivity of two approaches was compared: quantitative real-time PCR
(qPCR) targeting the P. falciparum 18S ribosomal RNA gene, either with an initial conventional PCR amplification
prior to qPCR (nested qPCR), or without an initial amplification (qPCR only). Parasite densities determined by nested
qPCR, qPCR only, and light microscopy were compared.
Results: Nested qPCR results in 10-fold higher sensitivity (0.5 parasites/μl) when compared to qPCR only (five
parasites/ul). Among microscopy-positive samples, parasite densities calculated by nested qPCR correlated strongly
with microscopy for both asymptomatic (Pearson’s r = 0.58, P < 0.001) and symptomatic (Pearson’s r = 0.70, P < 0.0001)
P. falciparum infections.
Conclusion: Nested qPCR improves the sensitivity for the detection of P. falciparum blood-stage infection from clinical
DBS samples. This approach may be useful for active malaria surveillance in areas where submicroscopic asymptomatic
infections are prevalent.
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Although light microscopy examination of peripheral
blood smears remains the gold standard for malaria diag-
nosis and enumerating Plasmodium parasites, more sen-
sitive molecular techniques that amplify parasite DNA
using polymerase chain reaction (PCR) are routinely ap-
plied in clinical studies and epidemiological surveys for* Correspondence: tuan.tran@nih.gov
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croscopic infections [1,2]. Moreover, sensitive diagnostic
assays are becoming increasingly important as malaria
eradication efforts seek to eliminate asymptomatic infec-
tions that serve as reservoirs for transmission [3,4].
Quantification of low-density infections allows for de-
termination of parasite growth dynamics in semi-immune
individuals [5] or in the context of controlled human ma-
laria infection during clinical vaccine trials [2,5-7]. Such
studies have employed quantitative real-time PCR (qPCR)
assays that have a detection limit of 0.02-0.06 parasites
per μl but required extraction of DNA from at least 50 μld. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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quirement for routine field studies. In contrast, dried filter
paper blood spots (DBS) have been a practical way to
archive parasite DNA for future analysis without the need
for cryopreservation in field settings. Prior studies have
shown that quantitative real-time PCR (qPCR) techniques
using genomic DNA obtained from DBS samples can
reliably detect only ~4 to 40 parasites per μl [9,10], which
is only a modest improvement in sensitivity relative to
thick-smear microscopy. Improving the ability to quantify
low-density blood-stage infections would be beneficial,
especially in studies in endemic areas where asymptomatic
infections are common and often submicroscopic. The
present study describes an approach that combines nested
PCR with qPCR to increase the sensitivity to detect and
quantify parasite DNA extracted from clinical DBS sam-




Clinical samples used in this study were obtained from an
ongoing prospective, cohort study of malaria immunity in
Kalifabougou, Mali that began in May 2011. The details of
this cohort have been previously described [9]. The Ethics
Committee of the Faculty of Medicine, Pharmacy, and
Dentistry at the University of Sciences, Techniques, and
Technology of Bamako and the Institutional Review Board
of the National Institute of Allergy and Infectious Diseases,
National Institutes of Health approved this study (NIAID
IRB Protocol # 11-I-N126). Written, informed consent
was obtained from adult participants and from the parents
or guardians of participating children before screening and
enrollment.
Study design and sample collection
Blood samples in this study were obtained during passive
and active malaria surveillance visits (occurring every two
weeks) in Kalifabougou from May 2011 to December 2011
as previously described [9]. For each participant, peripheral
blood was collected by fingerprick for 1) DBS samples
archived on 903 Protein Saver filter paper (Whatman) and
stored at 25°C with silica desiccant in sealed foil envelopes
and 2) thick blood smears. Blood smears were stained with
Giemsa, and P. falciparum parasites were counted against
300 leukocytes. Parasite densities were recorded as the
number of asexual parasites/μl of whole blood based on an
average leukocyte count of 7500 cells/μL. During symp-
tomatic visits, contemporaneous blood smears were per-
formed for malaria diagnosis and appropriate treatment
was initiated per the National Malaria Control Programme
guidelines in Mali. Symptoms that initiated a diagnostic
evaluation for malaria included fever, chills, sweats, fatigue,
headache, nausea, vomiting, and general malaise.Sample preparation
Initial screening for P. falciparum infections was per-
formed using a non-quantitative, nested PCR technique
that detects parasite DNA directly from a 1-mm circular
punch of DBS at a sensitivity of ~1 parasite/μl as pre-
viously described [9]. For each participant, blood-smear
microscopy and non-quantitative, nested PCR were per-
formed on blood samples in chronological order starting
from the initial enrolment visit until the first P. falciparum
infection was detected. For DBS samples identified as
P. falciparum-positive by this initial screen, genomic DNA
(gDNA) was extracted from three 3-mm circular punches
containing uniform amounts of blood using the QIAmp
DNA Mini kit (Qiagen) per the manufacturer’s protocol
with a final elution volume of 150 μl of AE buffer. The ex-
traction protocol was followed rigorously to ensure that
the final DNA concentration reflected the maximum ob-
tainable yield. Parasite density calibration standards were
generated from 10-fold serial dilutions of purified plasmid
DNA containing a single copy of the P. falciparum 18S
ribosomal RNA (rRNA; MRA-177, MR4, ATCC) [11] at
concentrations of 109 copies/μl down to 1 copy/μl diluted
in PCR-grade water and gDNA extracted from a DBS
sample from a P. falciparum-infected patient with a
known parasite density of >500,000 parasites/μl as deter-
mined by light microscopy at concentrations of ~500,000
parasites/μl down to 0.05 parasites/μl diluted in water
containing gDNA from an uninfected donor (henceforth
referred to as “infected standard”). P. falciparum (3D7)
gDNA was isolated from parasite cultures with >4% para-
sitaemia at schizogony using the QIAmp DNA Mini kit.
DNA concentrations were determined by spectrophotom-
etry (Nanodrop Lite, Thermoscientific).
Conventional PCR amplification followed by nested
quantitative real-time PCR
Primer sequences and references are listed in Table 1. Ini-
tial rounds of amplifications were performed in 25 μl reac-
tions containing 1 μl of template DNA, 0.5 μM of PLU5/
PLU6 forward and reverse primers, and 1x KAPA2G Fast
HS Ready Mix (Kapa Biosystems). In a conventional ther-
mocycler, the template DNA was denatured at 95°C for
5 min, followed by 15 cycles of amplification (95°C for
30 s, 61°C for 30 s, and 72°C for 1 min) and a final exten-
sion at 72°C for 1 min. A reaction using 1 μl of PCR-grade
water in lieu of template DNA was always included as a
negative control in this first round of amplification.
For the second round of amplification, 1 μl of the PCR
product from the initial amplification was used as the
template in a qPCR reaction (20 μl final volume) contai-
ning 0.2 μM FAL1/FAL2 forward and reverse primers and
1X Power SYBR Green Master Mix (Applied Biosystems).
Reactions were performed in 384-well optical PCR plates
on an Applied Biosystems 7900HT Fast Real-Time PCR
Table 1 Primers used for nucleic acid amplification
Primer name Sequence Reference
rPLU5 5′ CCTGTTGTTGCCTTAAACTTC 3′ Snounou, G. et al. 1993 [12]
rPLU6 5′ TTAAAATTGTTGCAGTTAAAACG 3′
rFAL1 5′ TTAAACTGGTTTGGGAAAACCAAATATATT 3′
rFAL2 5′ ACACAATGAACTCAATCATGACTACCCGTC 3′
Human GAPDH F2 5′ CGACCACTTTGTCAAGCTCA 3′ Smith, P.H. et al. 2011 [13]
Human GAPDH R2 5′ GGTGGTCCAGGGGTCTTACT 3′
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meters (50°C for 2 min, 95°C for 10 min followed by 40 cy-
cles of amplification [melt at 95°C for 15 s, anneal/extend
at 60°C for 1 min]) with the addition of a dissociation
stage for subsequent melting curve analysis. In addition,
1 μl of serially diluted P. falciparum plasmid and infected
standards were used as direct templates (i.e. without prior
amplification) for qPCR reactions.
The nested qPCR protocol was originally tested using
10, 15, 20, 25, and 30 cycles for the initial amplification,
with 15 cycles yielding the largest absolute difference in
threshold cycle (Ct) values between the sample with the
lowest and highest gDNA dilutions. Each experimental
run included, as Plasmodium negative controls, a no
template control (PCR-grade water as noted above) and
gDNA extracted from donors previously determined to
be Plasmodium negative by PCR, and, as positive
controls, P. falciparum (3D7) gDNA, and the serially
diluted, infected standard. All samples were run in dupli-
cate or triplicate. As a DNA extraction control, real-time
PCR was also performed on gDNA extracted from DBS
using the human GAPDH primers in lieu of FAL1/FAL2
primers (Table 1).
Quality assurance using external DBS samples
To validate the assay, the above protocol was run using
gDNA extracted from DBS samples provided by an
external laboratory and used in a recent study on quality
assurance of Plasmodium PCR [14]. After determining
calculated parasite densities using the protocol described
herein, operators were un-blinded to the parasite densities
calculated by the external laboratory, which employed a
different qPCR protocol targeting the P. falciparum lactate
dehydrogenase gene as previously described [15].
Data analysis
ABI PRISM 7900 SDS software (version 2.4; Applied
Biosystems) was used to evaluate the amplification and
dissociation curves and determine the Ct values. Statistical
analyses were performed in Prism 6.0 (GraphPad). Para-
site densities (parasites/μl) and starting copy number of
P. falciparum 18S rRNA plasmid from the standards were
plotted against Ct values derived from the nested qPCR
assay to generate standard curves. For all samples with“unknown” parasite concentrations, parasite densities
were estimated from a regression line fit to the linear part
of the standard curves using the average of nested qPCR-
derived Ct values (performed in duplicate for all samples).
The strength and significance of correlations were as-
sessed with the Pearson’s correlation coefficient.
Results
Standard curves plotting Ct values against starting copy
numbers or parasite densities (parasites/μl) were gene-
rated from serially diluted plasmid DNA containing the
P. falciparum 18S rRNA gene or infected standard, re-
spectively, for both 1) 15-cycle standard PCR amplification
followed by nested qPCR and 2) amplification by qPCR
only (Figure 1). Based on an estimate of 6 copies of 18S
rRNA per P. falciparum genome [10], the limit of de-
tection using P. falciparum 18S rRNA plasmid is 0.17
parasites/μl (equivalent to 1 copy/μl) for nested qPCR
and 17 parasites/μl copies by qPCR only (equivalent to
100 copies/μl; Figures 1A and 2A). Similarly, the limit of
detection using infected standards is 0.05 parasites/μl
for nested qPCR and five parasites/μl for qPCR only
(Figures 1B and 2B). To evaluate whether the two different
sources of template DNA (P. falciparum 18S rRNA plas-
mid versus infected standard) yielded directly comparable
parasite density estimates based on their Ct values, the Ct
values generated by nested qPCR were plotted against the
parasite densities estimated from copy number for P. fal-
ciparum 18S rRNA plasmid or corresponding to the dilu-
tions in the case of infected standards (Figure 1C). A
strong, negative correlation existed between parasite dens-
ity and Ct values when values from both sources were
combined (Pearson’s r −0.99; 95% CI [−1.0 to −0.96];
P < 0.001). High Ct values (>33 cycles) generated in sam-
ples with no template during the first amplification
(Figure 2A) were confirmed as negative by inspection of
dissociation curves (Additional file 1).
Parasite densities derived from nested qPCR were cor-
related to parasite densities determined by microscopy
of concurrent blood smears for smear-positive patients
who were either symptomatic or asymptomatic at the
time of DBS collection (Figure 3). Parasite densities cal-
culated by nested PCR correlated strongly with both
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Figure 1 Comparison of quantitative real-time PCR standard curves. 10-fold plasmid or gDNA dilutions were plotted against Ct values
generated from qPCR only and nested qPCR assays using (A) P. falciparum 18S rRNA plasmid or (B) gDNA extracted from dried blood spots
obtained from a subject with clinical malaria as template DNA (described in the Methods). Points represent the mean of technical duplicates and
error bars (where visible) indicate the standard deviation. Dotted lines represent the technical limit of detection as defined as the lowest template
concentration for which there is a linear relationship between Ct values and copy number/parasite density. For (C), Ct values generated by
nested qPCR were plotted against the parasite densities estimated from copy number for P. falciparum 18S rRNA plasmid or corresponding to the
dilutions from the clinical DBS standards. The best-fit regression line is shown as a black line.
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[0.53 to 0.81], P < 0.0001) P. falciparum infections. For
asymptomatic patients who had negative blood smears
but were positive by the non-quantitative nested PCR
screen, the median parasite density derived from nested
qPCR was 220 parasites/μl (interquartile range, 3.6-5100).
Correlation of calculated parasite densities in
independently validated P. falciparum DBS samples
Calculated parasite densities for 8 external DBS samples de-
termined using our nested qPCR assay strongly correlated
with values determined by an independent qPCR assay [15]
(Pearson’s r 0.99, 95% CI [0.96 – 1.0], P < 0.0001).
Discussion
Accurate quantification of low-density parasitemia from
DBS samples has become increasingly important in cli-
nical studies of malaria in which the kinetics of early or
treated infection are approximated and for the identifica-
tion of submicroscopic infections that serve as occult
reservoirs for malaria transmission. In contrast to ampli-
fication protocols that quantify Plasmodium nucleic acid
extracted from cryopreserved blood samples, which have
a sensitivity of 0.02-0.06 parasites/μl [4], protocols em-
ploying direct qPCR of parasite gDNA extracted from
clinical DBS samples typically cannot quantify samples
with <5 parasites/μl [10,14]. Nested qPCR, in which the
product of the initial conventional PCR is used as the
template for a second amplification with quantitative
real-time PCR, has been used successfully to increase
assay sensitivity in the diagnosis of tuberculous meningi-
tis [16], respiratory viruses [17] and, more recently, Plas-
modium infection [18].
In this report, a qPCR-only approach was directly
compared to nested qPCR using standard curves gene-
rated with gDNA from actual clinical DBS samples as
well as plasmid DNA. By incorporating a nested amplifi-
cation with qPCR, the limit of detection was increased
by about two orders of magnitude over a qPCR-only ap-
proach (Figure 1). However, a conservative estimate of
the limit of quantification, and thus the practical sensi-
tivity of the nested qPCR assay, is ~0.5 parasites/μl
based on the increased variance at the lowest detectable
dilutions and reproducibility with infected standard
curves performed by multiple operators. This compareswell with the sensitivity of ~2 parasites/μl in a recent study
which also used a nested qPCR approach [18] with the
small difference in sensitivity possibly attributable to the
amount of whole blood initially used (5 μl versus ~10 μl
from three 3-mm punches in this study) and differences in
DNA extraction protocols, master mixes, and cycling
parameters. Notably, the results here indicate that a
P. falciparum 18S rRNA plasmid-based standard curve
can be a reliable option in cases where high-parasitaemia
clinical samples are not available, as parasite density esti-
mates from Ct values are remarkably similar irrespective
of whether the standards were prepared from plasmid
DNA or gDNA extracted from a clinical DBS sample.
The importance of highly sensitive molecular diagnos-
tics in clinical trials of malaria vaccine and therapeutic
candidates and in campaigns to eliminate parasite reser-
voirs in endemic populations has placed an emphasis on
proper standardization and quality assurance of nucleic
acid testing protocols [4,14]. The strong correlation
between parasite densities calculated from the nested
qPCR assay described herein with those from an in-
dependent protocol [15] provides confidence that the
nested qPCR assay described here generates results that
may be directly comparable to other studies using vali-
dated qPCR protocols. Furthermore, we also tested our
assay over a wide range of parasitaemia from clinical
DBS samples to evaluate its utility for field isolates. For
patent infections, parasite densities derived from nested
qPCR Ct values correlate well with those determined by
microscopy both for symptomatic and asymptomatic
cases (Figure 3). For submicroscopic infections, qPCR
generally overestimates the parasite densities. One pos-
sible explanation is that thick blood smears generally
underestimate the true parasite density due to parasite
loss during staining [19] and, in the case of the highly
discordant samples, the loss may have been particularly
marked. Another explanation may be reduced precision
between replicates due to small volumes of template
used in the reactions. One microliter of PCR product
was used as the template for the second amplification to
maximize the dynamic range of the assay, which allowed
quantification of either submicroscopic or high-density
parasitaemia using a single protocol. However, if only
submicroscopic or low-density parasitaemia is being con-
sidered, increasing the template volume for the second
AB
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Figure 2 Amplification curves for nested qPCR assay. Nested qPCR amplification curves using 10-fold serial dilutions of (A) P. falciparum 18S rRNA
plasmid or (B) gDNA extracted from dried blood spots obtained from a subject with clinical malaria as template DNA (described in the Methods).
Tran et al. Malaria Journal 2014, 13:393 Page 6 of 8
http://www.malariajournal.com/content/13/1/393

























microscopy limit of detection
Figure 3 Correlation between parasite densities determined by light microscopy and calculated by nested qPCR. Calculated parasite
densities from nested qPCR were plotted against parasite densities determined by light microscopy for symptomatic infections (red circles),
asymptomatic infections with positive blood smears (black circles), and asymptomatic infections with negative blood smears (unfilled circles).
Parasite densities calculated by nested PCR strongly correlated with both asymptomatic (Pearson’s r = 0.58, 95% CI [0.29 to 0.77], P < 0.001) and
symptomatic (Pearson’s r 0.70, 95% CI [0.53 to 0.81], P < 0.0001) P. falciparum infections. The dashed line represents the limit of detection for
blood-smear microscopy (~40 parasites/μl).
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the sensitivity of the assay. Conversely, on occasion nested
qPCR underestimated the parasite density relative to
microscopy, but much less frequently (Figure 3). This
phenomenon might be explained by the presence of
human gDNA interfering with amplification of the para-
site gene rather than inefficient DNA extraction, given
that appropriate extraction was verified by the presence of
human GAPDH.
A major limitation with the nested qPCR approach is
the increased chance of false positives given the two
cycles of amplification. Thus, care must be taken to re-
duce the possibility of false positives due to contami-
nation. Of note, amplification curves were occasionally
observed to have Ct values of >32 cycles for the negative
(no template) control (Figure 2A), but these consistently
appear to be primer dimers by dissociation curve ana-
lysis (Additional file 1).
Based on these findings, it is recommended that a
negative control reaction always be included with the
first amplification and that any Ct value within 2 cycles
of the negative control be considered negative with ad-
ditional confirmation by dissociation curve analysis. One
way to minimize false positives is to always employ an
initial screen for Plasmodium infection using a conven-
tional nested PCR approach (based on the original assaydescribed by Snounou et al. [12]), and selecting only con-
firmed P. falciparum-positive samples for subsequent
quantification with nested qPCR as done in this study.
This two-step screening approach, although more time-
intensive, would also minimize expending qPCR reagents
on uninfected samples in malaria surveillance studies.
The nested qPCR approach in this study may be par-
ticularly convenient in laboratories that already employ
the standard nested PCR protocol developed by Snounou
et al. [12] given that the same primer sets are shared bet-
ween the protocols. Although this assay was only validated
for the quantification of P. falciparum parasitemia, ap-
plying a nested qPCR approach to the other four human
Plasmodium species would be relatively straightforward if
species-specific Plasmodium 18S rRNA primers were used
during the real-time amplification, as was done in a recent
study [18].
Conclusions
The nested qPCR assay presented here reliably quantifies
parasite densities from DBS samples obtained from sub-
jects with asymptomatic and symptomatic malaria and
achieves higher sensitivity than a qPCR-only approach.
This assay may be useful for active malaria surveillance
in areas where submicroscopic asymptomatic infections
are prevalent.
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